Degradat
CancerDip
home
Introduction
Objectives
News
Consortium
Links
Publications
Contact
Workshop
Esteller
Fuks
Stunnenberg
Altucci
Lengauer&Bock
Magdalena
François Fuks undertook his postdoctoral training on DNA methylation and histone modifications in Prof Kouzarides’s laboratory in Cambridge, a world leader group on epigenetic. Dr. Fuks then started his own lab in Brussels, the Laboratory of Cancer Epigenetics, where he further investigated the link between DNA and histone modifications. This lab is the first in Belgium working on epigenetic modifications and their involvement in cancer. Over the years, F. Fuks’ lab has contributed to important new findings in the epigenetic field.
Fuks
 
The leadership of the team demonstrated by Dr. Fuks and his management of the different projects are prooving successful, as exemplified by the publication of his work as senior author in high-quality journals such as EMBO J. or Nature. Regarding the CANCERDIP project, François Fuks discovered a novel connection between two key epigenetic systems:
DNA methylation and the Polycomb proteins (Viré et al., Nature 2006). In that respect, the lab of Dr. Fuks has acquired technical expertise and has developped several assays and tools regarding the link between DNA methylation and Polycomb. For exemple, this lab found novel DNMT- and PcG-target genes, developed DNA methyltransferase assays and stably introduced into cells by retroviral transduction vectors siRNAs directed against every DNA methylation component as well as against PcG proteins. Dr. Fuks benefits from very good infrastructures to work on epigenetic at the Free University of Brussels and has all the facilities needed to perform the outlined work.

Rzeżączka Rzeżączka
Schorzenia narządów płciowych możesz leczyć szybko i skutecznie!
choroby-weneryczne.pl/rzezaczka.html


chlamydia Chlamydia
Pokonaj dokuczliwą infekcje intymną!
choroby-weneryczne.pl/chlamydia.html

 

See: Laboratoire d'Epigénétique du Cancer (François Fuks)

 

François Fuks
| CANCERDIP is funded under the European Commission's 7th Framework Programme for Research and Technological Development |
line
The Use of MeDip in Cancer for Better Clinical Management
line